PRX302

· Sophiris Bio Corp

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for PRX302, covering 2009-10-29 to 2019-04-10. Get the full timeline:

Most recent: Clinical Trial Update: Intraprostatic PRX302 Injection to Treat Localised Prostate Cancer [Phase 2]